IndraLab

Statements



reach
"Further, while the IKKbeta inhibitor TPCA-1 inhibited p65 activation, knockdown of TRAF3IP2 blunted both IKKbeta kinase activity and p65 phosphorylation."

reach
"Moreover, TPCA-1 markedly inhibited the binding of RelA, but not that of Eomes or NFATc2 to the IFN-γ promoter."